Ashmore acquires 85% stake in Colombian healthcare provider SOHEC

Posté le 15 août 2023

Ashmore, a UK-based specialist emerging markets investment manager, has acquired an 85% stake in SOHEC, a Colombian healthcare provider specializing in treatments associated with chemotherapy and radiotherapy, and which also operates a well-renowned clinical research center.

SOHEC is located in Valledupar, Colombia, which has served as a leader in the prevention, treatment, and research of cancer in the northern region of the country during the past 27 years.

The company focuses on providing research studies to promote reliable and high quality treatments to the institution's patients, supported by constant innovation, clinical research and state-of-the-art technology.

Ashmore is a specialist Emerging Markets investment manager with over 30 years' experience in providing opportunities for investors to participate in such markets.

The firm’s Andean Fund III made the investment in SOHEC.

Ashmore Colombia will continue to work with SOHEC's existing management team and employees to further develop the company's growth and the development of mechanisms for cancer prevention, treatment and research in Colombia.

Ashmore was counseled in Colombia by law firm Posse Herrera Ruiz, with a team led by partners Jaime Herrera and Alejandro Turbay, and who were assisted by Paola Soler, Carolina Castro, Sergio Salazar, David Celís and Alejandro Ávila.

The team of Cuatrecasas Colombia that was involved was: Felipe Mariño, (partner) Camilo Cardona (senior associate), Sebastián Salazar (senior associate), Natalia Márquez (associate), Andrés Saldarriaga (associate).